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ABSTRACT 
Male Sprague-Dawley rats of 200-250 g we~e assigned to ad libitum 
feeding of ground Purina Rat Chow as such or supplemented with O. 25, 
0.50, 0.75, and 1.0% (W/W) carnitine for 1-6 days. In the first 
experiment, a control versus a 1% carnitine supplemented group was 
studied for 6 days, and in the second experiment, a control versus 0.25, 
0.50, 0.75, and 1.0% carnitine supplemented groups were investigated for 
5 days. A dose of ethanol, (3 g/kg body weight), was administered via a 
gastric gavage to all animals and blood-ethanol levels were monitored in 
the tail blood at 2, 5, and 8 hours postethanol administration. In the 
second experiment blood-carnitine levels were also followed at 1, 3, and 
5 days of supplemental feeding. Results of both experiments show that 
at all levels carnitine supplemented animals had higher blood-ethanol 
concentrations than those not supplemented with carnitine. The levels 
of carnitine supplementation were highly correlated with blood-ethanol 
concentrations as well as with blood-carnitine levels. While 1% and 
0.5% or 0.75% supplementation resulted in steady state levels of carni-
tine in the blood at 3 and 5 days, respectively, 0.25% supplementation 
caused a linear increase in blood-carnitine levels at least up to 
5 days. An estimation of blood-ethanol levels at or near zero time 
postethanol administration was made by extrapolating the lines used for 
calculating the rate of disappearance of ethanol. This showed that the 
ethanol concentration in the blood of carnitine treated animals was 
significantly higher than that present in the controls at or near zero 
time, suggesting that carnitine may be increasing the rate of ethanol 
iv 
absorption rather than inhibiting the rate of disappearance from the 
blood. 
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CHAPTER I 
INTRODUCTION 
It is known that the intake or administration of ethyl alcohol both 
in humans and in laboratory animals has consistently resulted in hyper-
lipidemia with a major elevation occurring in the serum triglycerides 
due to a decrease in hepatic fatty acid oxidation (1, 2). Because 
ethanol has an obligatory hepatic metabolism (3), hyperlipidemia and 
hepatic steatosis are common features of alcohol-induced alterations of 
fat metabolism. This is partly due to the reduced oxidation of fatty 
acids (4) and in part, due to enhanced fatty acid biosynthesis from 
readily available acetate and NADPH in an ethanol compromised liver (4). 
Carnitine (3-hydroxy-4-N-trimethyl-aminobutyrate) is known to 
enhance fat metabolism by facilitating the transport of fatty acids into 
mitochondria (5, 6). Thus carnitine is needed for the efficient oxida-
tion of fatty acids for energy, and in the absence of carnitine, intra-
mitochondrial oxidation of fatty acids will not occur in various organs. 
Only a few studies have been carried out in which attempts have been 
made to correlate carnitine status with the ethanol-induced hepatic 
steatosis. The most recent studies of Sachan and Rhew (7, 8) in this 
regard shed a considerable light on the lipotropic effect of carnitine 
in a chronic alcoholic condition. Their studies (7, 8) have clearly 
shown that 1% dietary carnitine raised hepatic carnitine concentrations 
and prevented excessive fat accumulation in the livers of ethanol fed 
rats. Further, their data aid in the understanding of the controversial 
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issue of carnitine deficiency (9) and sufficiency (10) in alcoholic 
cases. However, the results of these studies posed a question about the 
possible effect of carnitine on the metabolism of ethanol itself. The 
studies described here were undertaken to answer this very question. 
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CHAPTER II 
REVIEW OF LITERATURE 
Ethyl Alcohol as a Drug 
Ethyl alcohol is a therapeutic agent of only moderate importance, 
but is primarily an hypnotic and anesthetic whose primary action is 
directed on the central nervous system (11). Because alcohol causes a 
depression of the higher brain centers which results in uninhibited 
behavior patterns of ·varying degrees, alcoholism has become a great 
social, medical, and toxicological problem (11). The effects of ethanol 
on the body are directly dependent on the concentration of ethanol in 
the blood. At any specified time, blood-ethanol concentration is 
dependent on four factors (11): 
1. The quantity and the rate of ethanol ingested. 
2. The rate of ethanol-absorption. 
3. The body weight and the percentage of body water. 
4. The rate of ethanol metabolism. 
The liver is the primary site of ethanol metabolism where 98% of 
ingested ethanol is oxidized to acetaldehyde and acetate. The main 
pathway responsible for this metabolism involves the cytosolic enzyme, 
Alcohol Dehydrogenase (ADH), which catalyzes the conversion of ethanol 
+ 
to acetaldehyde with concommitant reduction of the cofactor NAD to NADH 
(11). 
+ CH3cH20H + NAD 
(Ethanol) 
ADH) + CH3CHO + NADH + H 
(Acetaldehyde) 
4 
+ As a result, there is an increased NADH/NAD ratio which has significant 
ef fee ts on intermediary metabolism in that it changes the levels of 
various metabolites in the body; e.g., a buildup of lactate, an increase 
in fatty acid synthesis, and an increase of ketogenesis (11). Ethanol 
may also be oxidized through an alternate pathway known as the hepatic 
Microsomal-Ethanol-Oxidizing-System (MEOS), which is a component of 
the Mixed-Function-Oxidase-System, (MFOS), known to be responsible for 
the metabolism of drugs and environmental chemicals (1). 
+ CH3cH 20H + NADPH + H + o2 
MEOS ) CH 3CHO + NADP + 2H2o 
(Ethanol) (Acetaldehyde) 
Thus, when ethanol is given in conjunction with a drug, the metabolism 
of either could be altered due to a synergistic and/or antagonistic 
effect of one on the other, possibly by affecting a common metabolic 
pathway or a receptor site (1). 
Effect of Ethanol on Drug Metabolism 
Studies have shown that while ethanol alters the half life of 
certain drugs, its own clearance from the blood is greatly influenced by 
various drugs both in humans and in experimental animal models. Rubin 
et al. (12) have found that acute ethanol ingestion resulted in a 
reduced clearance of pentobarbitol and meprobamate in the blood of human 
volunteers and rats.. This ef feet by ethanol was found to have heen 
mediated via inhibition of hepatic microsomal drug-metabolizing enzymes 
resulting in decreased clearance from the blood. This metabolic 
interrelationship may explain the heightened sensitivity of inebriated 
persons to these kinds of drugs (12). For these reasons, a chronic 
alcoholic individual will have a greater tolerance for ethanol and other 
drugs when one or the other is administered separately (12). Some of 
the tolerance to ethanol may be attributed to a central nervous system 
adaptation (13). It was found that chronic alcoholism increased the 
clearance of meprobamate from the blood in four volunteers when tested 
one month after being on an alcoholic regimen (13). Thus, the metabo-
lism of meprobamate was accentuated by the ethanol-induced MEOS of these 
individuals resulting in a greater tolerance to the drug. 
Hoyumpa et al. (14) found that when ethanol, (3 g/kg body weight), 
was administered to male dogs one hour prior to intravenous adminis-
tration of either 100 mg/kg body weight of Librium, 1 mg/kg body weight 
of demoxepan, (a Librium metabolite), 1 mg/kg body weight of Valium, or 
1 mg/kg body weight of desmethyldiazepam, (a metabolite of either 
demoxepan or Valium), the ethanol had no effect on the systemic clear-
ance of either the Librium or the Valium but reduced the clearance of 
the two metabolites, which are responsible for the enhanced sedation. 
Thus, ethanol affects the clearance of the metabolites and not the 
parent compounds themselves (14). 
It is important to examine the effects of various drugs on the 
blood-level of alcohol. Pirola (15) concluded that drugs with anti-
cholinergic activity, e.g., Atropine or Donnatol, can slow the rate of 
ethanol absorption because of the delayed gastic emptying that is 
encountered with these drugs. Conversely, drugs which promote gas tic 
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emptying, e.g., nicotine or clofibrate, may speed up ethanol absorption. 
Diuretics also play a role in the shifting of blood-alcohol levels by 
affecting ethanol distribution. Eskelson et al. (16) found that when an 
experimental diuretic, DH-524, and doses of ethanol were given concur-
rently to rats, there was a sizable decrease in the blood-ethanol con-
centrations. This was suggested to have occurred due to a decrease in 
the sizes of the various body-water compartments (16). This finding may 
have direct implications in patients who simultaneously take diuretics 
while drinking alcohol. 
Effect of Drugs on Ethanol Clearance 
There are drugs that retard and those that accelerate ethanol 
clearance from the blood. Only a few drugs are known to inhibit ethanol 
metabolism. Sellers et al. (17) found that chloral hydrate inhibited 
the metabolism of ethanol in human subjects given acute alcohol doses. 
It was observed that an active metabolite in chloral hydrate, trichloro-
ethanol, is a competitive inhibitor of Alcohol Dehydrogenase and it 
competes sufficiently to slow the oxidation rate. It was also observed 
by Mezey (18) that the administration of chlorpromazine in large doses 
inhibits ADH and prolongs the effect of ethanol in humans. The most 
common drug used to inhibit ethanol metabolism is disulfiram (Antabuse). 
Disulfiram inhibits the metabolism of the acetaldehyde produced from 
ethanol by inhibiting Acetaldehyde Dehydrogenase (19). In patients 
drinking alcohol while taking disulfiram, the "Antabuse" reaction is 
provoked by causing vasodilation, nausea, vomiting, and confusion, 
7 
partly attributed to acetaldehyde accumulation in the blood (19). It 
should also be noted that both organic and inorganic nitrates can 
inhibit ethanol metabolism (20) and that oral contraceptives containing 
estrogen may reduce the rate of ethanol metabolism (21). 
On the other hand, there are drugs that have been observed to 
accelerate ethanol metabolism. This is brought about by three possible 
ways: (1) by increasing MEOS activity, (2) by increasing the liver size 
or perfusion rate, and (3) by increasing the oxidative state of hepato-
cytes so that the enhanced + hepatic NADH/NAD ratio, due to ethanol 
administration, is reversed (18, 19). Phenobarbitone increases MEOS 
activity in both man and experimental animals if administered for a 
number of weeks (19). An increased perfusion rate and liver size in 
addition to an increased bile flow induced by phenobarbitone probably 
contribute to the increased rate of ethanol metabolism ( 18). Hawkins 
et al. (22) found that clofibrate administered in doses ten-fold above 
those used clinically, increased the rate of ethanol metabolism in.the 
rat. This increased metabolic rate is directly correlated with the 
increase of liver weight induced by clofibrate. Lundquist and Wolthers 
(23) and Brown et al. (24) found that fructose, when given in high 
doses, speeds up the rate of ethanol metabolism in man. The mechanism 
by which ethanol metabolism is accelerated by fructose may be due to the 
formation of glyceraldehyde, an intermediate of fructose metabolism, 
which can induce a dissociation of the ADH-NADH complex (19). 
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Ethanol-Carnitine Correlation 
Ethanol is known to decrease fatty acid oxidation and to enhance 
fatty acid synthesis and esterification in the liver (25, 26). In a 
study by Kondrup and Grunnet (10), it was found that the contents of 
both free carnitine and acetyl carnitine were increased by 50% in the 
livers of rats after acute ethanol administration, whereas that of acyl 
carnitine, (long-chain), was decreased by 50%. Furthermore, carnitine 
acylation ratio was decreased by 60%. Thus it was concluded that the 
ethanol treated rats acylated carnitine to a lesser degree than those 
without ethanol. 
The degree of carnitine acylation may reflect the state of fat 
metabolism since this compound mediates the activation and transfer of 
acetyl and acyl units (10). Apparently, the carnitine acylation ratio 
does reflect the direction of hepatic fat metabolism which is decreased 
in rats subjected to acute ethanol treatment. Under these conditions, 
fatty acid synthesis and esterification are enhanced (10). Lieber 
et al. (26) suggested that the ethanol induced triglyceride accumulation 
may be a consequence of decreased fatty acid oxidation owing to de-
creased Tricarboxylic Acid Cycle activity. Rudman et al. (9) hypothe-
sized possible carnitine deficiency in alcoholic cirrhotic patients 
while Hasein and Bexton (27) demonstrated beneficial effects of dietary 
carnitine in ethanol fed rats. It was Sachan et al. (7, 8) who sug-
gested that although small changes in acyl carnitine to carnitine ratio 
may not be disregarded, the profound lipotropic effect of dietary 
9 
carnitine in alcohol induced hepatic steatosis must be brought about by 
some other mechanism such as an altered ethanol oxidation rate and/or 
the elimination of acyl carnitine in the urine. 
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CHAPTER III 
EXPERIMENTAL PROCEDURE 
Ethanol Feeding with Carnitine Supplementation 
Experiment I--An Acute Ethanol Dose 
with a Single Level of Supplementary 
Carnitine 
This study was conducted using male, Sprague Dawley rats of 200-
250 g body weight and divi<led into 2 groups of 4 animals. They were 
individually housed in 7" x 10" x 7" wire mesh stainless steel cages and 
provided feed and water ad libitum. The diet consisted of ground Purina 
Rat Chow #5012 (Ralston Purina Co., St. Louis, Mo.). The animals of the 
control group were given this diet as such while the diet of the test 
group was supplemented with 1. 0% (W /W) D, L-carni tine (Sigma Chemical 
Co., St. Louis, Mo.) on a dry weight basis. The 1. 0% test diet was 
premixed with D,L-carnitine in bulk. 
The assigned diets were fed to animals in each group for 6 days 
following which a single dose of absolute ethanol was administered by 
way of a gastric gavage. This was accomplished with a 10 cc syringe 
with an attached blunt-end, curved, stainless steel cannula to ensure 
proper esophageal-stomach entrance without trauma. The dose of ethanol 
for each animal was 3 g absolute ethanol/kg bo<ly weight in an aqueous 
13% solution, similar to that used by Kondrup and Grunnet (10). Blood 
was drawn from the tail of each animal at 0, 2, 5, and 8 hours post-
ethanol administration. The dorsal tail vein was exposed by making an 
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incision over the vein. The vein was pricked and blood was collected in 
a 20 µ1 capacity heparinized Micro-hematocrit capillary tube (Clay 
Adams, Parsippany, N.J.). The contents of the capillary tube was 
immediately delivered into a 1. 5 ml capacity microfuge tube (Walter 
Sarstedt, Inc., Princeton, N.J.) containing 980 µ1 of cold normal 
saline. The total volume of 1 ml was further processed for determining 
blood-ethanol levels as described in the section "Blood-Ethanol Determi-
nation." 
Experiment 11--An Acute Ethanol Dose 
with Multiple Levels of Supplementary 
Carnitine 
This study was conducted using male, Sprague Dawley rats of 
220 g body weight and divided into 5 groups of 3 animals. The diet 
consisted of ground Purina Rat Chow #5012. The animals of the control 
group were given this diet as such, while the diet of the test groups 
were supplemented with 0.25%, 0.50%, 0.75%, and 1.0% (W/W) D,L-carnitine 
on a dry weight basis. The test diets were premixed with D,L-carnitine 
in bulk. 
The assigned diets were fed to the animals for 5 days following 
which a single dose of absolute ethanol was administered by way of a 
gastric gavage. The general procedure followed here was identical with 
that used in experiment I, except that on days 1, 3, and 5, 50 to 70 µ1 
of additional blood was drawn from the tails of each animal for the 
determination of blood-carnitine. The procedure used for collecting 
blood was the same as that used for blood-ethanol, except that the blood 
from the capillary tube was delivered into a dry microfuge tube and 
immediately frozen. 
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Blood-Ethanol Determination 
Blood-ethanol concentrations in each sample were determined by the 
modified procedure of Bernt and Gutmann (28). The test is based on the 
+ principle that ethanol is oxidized by NAD and Alcohol Dehydrogenase, 
(ADH), to yield NADH and acetaldehyde as follows: 
+ Ethanol+ NAD ADH , + Acetaldehyde + NADH + H 
The formation of NADH is measured spectrophotometrically by monitoring 
+ 
the increase in extinction at 340 nm. The amount of NADH + H formed is 
proportional to the amount of ethanol present in a sample. 
Reagents 
1. Sodium Pyrophosphate buffer (75 mM pyrophosphate buffer, 
pH 8.7, 75 mM semicarbazide, 21 mM glycine): 10 g Na4P2o7 •10 H20, 2.5 g 
semicarbazide HCl and O. 5 g glycine were dissolved in 250 ml of glass 
distilled water (Corning Mega-Pure, Corning, N.Y.), adjusted to pH 8.7 
with about 5 ml of 4N KOH and diluted to 300 ml with glass distilled 
water. 
2. Nicotinamide-adenine dinucleotide (24 mM B-NAD): 50 mg of NAD 
(Sigma Chemical Co., St. Louis, Mo.) was dissolved in 3.0 ml of glass 
distilled water. 
3. Alcohol Dehydrogenase: 30 mg of lyophilized enzyme (CalBio-
chem-Behring Corp., La Jolla, Ca.) was dissolved in O. 5 ml glass dis-
tilled water. 
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4. Ethanol stock standard (0.5% (V/V) absolute ethanol): 0.125 ml 
of absolute ethanol was diluted to 25 ml of glass distilled water. The 
working standard was prepared by diluting the stock standard 50-fold. 
One ml of the stock standard was diluted to 50 ml with cold normal 
saline. 
Procedure 
A reaction mixture was prepared by mixing 2. 38 ml of the Sodium 
+ Pyrophosphate buffer, 0.1 ml of NAD , and 0.02 ml of ADH, making a total 
volume of 2.5 ml of the mixture for each sample tested. Ethanol stan-
dards were prepared by diluting the working standard, using 0-100 µ1, 
with cold normal saline. All standards and samples were centrifuged for 
2 minutes at 1500 RPM in an Eppendorf Centrifuge, 5412 (Brinkman Instru-
ments, Inc., Westbury, N.Y.) A 0.1 ml aliquot of supernatant from all 
standards and samples was added to 12 x 75 mm Pyrex test tubes followed 
by 2. 5 ml of the reaction mixture. The contents of each tube were 
mixed, incubated for 25 minutes in a 37°C water bath, and after cooling 
to room temperature, the absorbance of each sample was determined in a 
spectrophotometer (Model 34, Beckman Instruments, Fullerton, Ca.) at 
340 mm. Ethanol concentration was calculated as follows: 
Ethanol (mg/dl whole blood)= Absorbance of Sample Slope of Standard Curve 
Blood-Carnitine Determination 
Blood-carnitine concentrations for samples taken on days 1, 3, and 
5 of D,L-carnitine feeding were determined by the radioisotopic 
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procedure of Cederblad and Linstedt (29) as modified in our own labora-
tory (8). Total carnitine in whole blood was determined by measuring 
free carnitine, acid soluble acylcarnitine (ASAC or short chain carni-
tine), and acid insoluble acylcarnitine (AIAC or long chain carnitine 
molecule) in each sample. The radiometric method for carnitine 
determination is based on the following enzymatic reaction: 
L-Carnitine + (1 - 14c) acetyl CoA ~~~ (1 - 14c) acetyl-carnitine 
+ CoASH 
The reaction mixture is passed through an anion exchange resin column 
which traps only the acetyl CoA. The labeled acetyl-carnitine passes 
through the column and the eluate is counted in a liquid scintillation 
counter. 
Reagents and Solutions 
la. Carnitine Standard Solution (O.S mM): L-Carnitine HCl (Sigma 
Chemical Co., St. Louis, Mo.) and the total volume was brought to 100 ml 
with glass distilled water in a volumetric flask. One ml aliquots were 
dispensed into plastic tubes and frozen at -70°C. Each aliquot was 
diluted appropriately for the working standard solution. 
lb. L-Palmityl Carnitine Standard (22.9 mM): 1.0 ml of glass 
distilled water was added to a vial containing 10 ml of L-Palmityl 
Carnitine (Sigma Chemical Co., St. Louis, Mo.). This was diluted 
appropriately for the working standard solution. 
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2. Potassium Hydroxide (1 N): 56.11 g of KOH pellets was 
dissolved in glass distilled water and the total volume was brought to 
1 liter with glass distilled water. 
3. Potassium Hydroxide (0.5 N): 28.055 g of KOH pellets was 
dissolved in glass distilled water and the total volume was brought to 
1 liter with glass distilled water. 
4. Perchloric Ac id ( 6 %) : 85. 71 ml of 70% Perchloric Ac id was 
added to 500 ml of glass distilled water and made to 1 liter. 
5. Sodium Tetrathionate (0.2 M Na2s4o6): 0.6756 g of Na2s4o6 was 
dissolved in glass distilled water and made to volume in a 25 ml volu-
metric flask. 
6. Phenol Red (0.1%): 0.1 g of Phenol Red was dissolved in 100 ml 
of absolute ethanol. (Phenol Red tubes were made by adding 1 drop of 
Phenol Red to 12 x 75 mm Pyrex glass tubes and allowed to dry.) 
7. Radioactive Acetyl Coenzyrne A, (SO mCi/rnrnole): 50 µCi of 
14 [1 - C] Acetyl Coenzyrne A (Amersham Corp., Chicago, 11.) was dissolved 
in 300 ml of cold glass distilled water. Aliquots of 5. 0 ml were 
dispensed into plastic vials and frozen at -60°C. 
8. Potassium Bicarbonate (2 M KHC0 3): 20 g of KHC03 was dissolved 
in glass distilled water and the total volume was brought up to 100 ml. 
This reagent was stored in a refrigerator. 
9. Acetic Anhydride [O.l M (CH3co) 2o]: 0.5 ml of (CHf0) 2o was 
added to 4.95 ml of cold glass distilled water, mixed, and used immedi-
ately for the Acetyl CoA solution. 
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10. Acetyl CoA (O.l mM): 10 mg of Coenzyrne A (P-L Biochemicals, 
Milwaukee, Wi.) was dissolved in 0.5 ml cold, glass distilled water. To 
this, 100 µl of 1 M KHC0 3 was added. Then, 200 µ1 of 0.1 M acetic 
anhydride was added and the volume was brought to 80 ml with glass 
distilled water. After mixing, the solution was dispensed into 5 ml 
volume tubes and frozen at -60°C. 
11. Carnitine Acetyltransferase (Pigeon Breast Muscle): Acetyl-
CoA: Carnitine-0-acetyltransferase (Sigma Chemical Co., St. Louis, Mo.) 
was diluted with glass distilled water to 50 units/ml. This enzyme is 
abbreviated as CAT in the procedure. 
12. MOPS (1 M) [3-(4-morpholino) propanesulfonic acid] (Eastman 
Kodak Chemical Co., Rochester, N.Y.): 20.92 g of MOPS was dissolved in 
approximately 80 ml of glass distilled water. The pH was adjusted to 
7.4 with 4 N KOH, and the volume was brought up to 100 ml with glass 
distilled water. 
13. PCA/MOPS-I: 20.9 g of MOPS was added to 50 ml of 6% PCA and 
made to a volume of 100 ml with glass distilled water. 
14. PCA/MOPS-II: 20.9 g of MOPS was added to 20 ml of 6% PCA and 
made to a volume of 100 ml with glass distilled water. 
15. EGTA, (0.1 M pH 7.0): 1.902 g of EGTA [Ethyleneglycol-bis(B-
amino-ethylether)N,N'-tetraacetic acid] (Sigma Chemical Co., St. Louis, 
Mo.) was dissolved in 30 ml of glass distilled water and neutralized 
with 4 N KOH to pH 7.0. The volume was then made to SO ml with glass 
distilled water in a volumetric flask. 
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16. 14 Radioactive Acetyl CoA mix (0.1 mM [1 - C]-acetyl CoA solu-
tion: 14 2 volumes of [1 - C] Acetyl CoA (#7) were mixed with 1 volume 
of cold 0.1 mM acetyl CoA (#10) and kept on ice. 
17. Reagent mixture for one assay: 
MOPS (1 M) buffer pH 7.4 (1112) 120 µl 
EGTA-K (0.1 M) pH 7.0 (Ills) 20 µl 
Na2s4o6 (0.1 M) (#5) 20 µl 
Radioactive acetyl CoA solution (0.1 mM) (t/16) 200 µl 
Glass Distilled Water 40 µl 
Total 400 µl 
18. Bovine serum albumin (8% Fraction V, F.A. poor from ICN Nutri-
tional Biochemicals, Cleveland, OH.): 4 g of BSA was dusted into about 
20 ml of glass distilled water and stirred. The volume was then made to 
50 ml with glass distilled water in a volumetric flask. 
19a. Scintillation Fluid A: 33 g of PPO (2,5 Diphenyloxazole) and 
1 g of POPOP (l,4-Bis(2-(5-Phenyloxazolyl)) Benzene) were dissolved in 
4 liters of Toluene (C6H5CH3). 
19b. Scintillation Fluid B: 2 parts of Scintillation Fluid A 
(#19A) was dissolved in 1 part Triton X-100 (Fisher Scientific Co., Fair 
Lawn, N. J. ) . 
Procedure 
Carnitine standards were prepared as shown in Table 1. For each 
sample tested, 20 µl of whole blood was added to 200 µl of 6% PCA con-
tained in a 12 x 75 mm Pyrex glass test tube. Since 400 µl was d~sired 
for the final volume, 180 µl of glass distilled water was added. All 
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standards and samples were vortexed and centrifuged (Model J-6B, Beckman 
Instruments, Palo Alto, Ca.) for 10 minutes at 1500 x g at 0°. 
Standard 
0.23 mM 
0.25 mM L-Palmityl 
Carnitine Carnitine 
(µ1) (nm) (µ1) (nm) 
0 0 0 0 
5 1. 25 5 1.15 
10 2.50 10 2.30 
15 3.75 15 3.45 
20 5.00 20 4.60 
1Glass distilled water. 
2 Bovine serum albumin. 
3Perchloric acid. 
Table 1 
Mixtures of 
GDW 1 
(µ1) 
100 
90 
80 
70 
60 
Carnitine 
8%2 
BSA 
6%3 
PCA 
(pl) (µ1) 
100 200 
Total 
Total Carnitine 
(µ1) (nm) 
400 0 
2.40 
4.80 
7.20 
9.60 
Free Carnitine Determination (per sample): 150 µ1 of PCA-superna-
tant was transferred into a 12 x 75 mm phenol red Pyrex test tube. The 
contents turned orange-yellow in color. Forty µ1 of 2 M KHC0 3 was added 
to the tube, where after standing, the mix turned a golden yellow. The 
mix was then vortexed and kept on ice, uncapped for 30 minutes, after 
which it was refrigerated. 
Acid Soluble Acyl Carnitine (ASAC) Determination (per sample): 
100 µl of PCA-supernatant was transferred into a 12 x 75 mm phenol red 
Pyrex test tube. The contents turned orange-yellow in color. Sixty µl 
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of 1 N KOH was added to the tube, and after vortexing, turned purple-
red. The tube was incubated for 30 minutes in a 37°C hot water bath for 
hydrolysis. After this time the contents were neutralized with 20 µl of 
PCA/MOPS-II. The mix was vortexed, kept on ice for 30 minutes, after 
which it was refrigerated. 
Acid Insoluble Acyl Carnitine (AIAC) Determination (per sample): 
The remaining supernatant in the tube was drained leaving only the 
pellet. After adding 1 drop of phenol red indicator to the tube, the 
pellet was taken up in 100 µ 1 of O. 5 N KOH. The tube was vigorously 
vortexed for several minutes until the pellet was completely dissolved 
in the KOH. The contents were purple-red in color. The tube was then 
hydrolyzed for 60 minutes at 65°C in a shaking incubator water bath 
(100 SPM). After hydrolysis, it was neutralized with 65 µl of PCA/MOPS-
I, where the contents turned a light yellow-orange. The tube was vor-
texed and kept on ice for 30 minutes. 
The Free, ASAC, and AISAC tubes were all centrifuged (Model J-6R, 
Beckman Instruments, Palo Alto, Ca.) for 10 minutes at 1500 x g at 0°. 
One hundred µl of supernatant were removed from all 3 tubes (per sample) 
for carnitine assay as per procedure. 
Assay for Carnitine: 100 µl of appropriate fractions of Free 
Carnitine, ASAC, and AIAC were transferred to 1.5 ml capacity microfuge 
tubes. Four hundred µl of the reagent mixture was added to each tube, 
after which, 20 µl of CAT was added, mixed gently, and incubated for 
30 minutes at 37°C in a hot water bath. At the end of the incubation 
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time, 200 µl of incubation mixture was transferred onto a mini column. 
Mini columns were prepared by using 5-3/4" Pasteur Pipettes (Fisher 
Scientific Co., Fair Lawn, N.J.) and stuffing the area above the tips 
with a small ball of glass wool. Anion Exchange Resin, AG I-X8, 200-400 
mesh, Cl-form (Bio-Rad Laboratories, Richmond, Ca.) was added up to the 
9 cm mark measured from the tip of the pipette. After the sample was 
absorbed, the column was washed with 2 portions of 500 µ1 of glass 
distilled water into a scintillation vial (New England Nuclear, Boston, 
Mass.). After washing, all columns were discarded into radioactive 
solid waste containers. To each scintillation vial, 10 ml of scintil-
lation fluid B was added, the vial was capped and mixed by swirling. 
All vials were placed in an LS-lOOC Liquid Scintillation Counter (Beck-
man Instruments, Irvine, Ca.) and radioactivity determinations were 
carried out. 
After the counts per minute (CPM) were recorded for all 3 sets 
(Free, ASAC, and AIAC) of tubes, the blank (zero) in each set was sub-
tracted from each standard and sample in that set. A standard curve was 
then plotted for each set. For each of the 3 fractions, to calculate 
the nmoles carnitine/ml blood, the following equation was utilized: 
I. S • x 5 0 x C PM 
where: 
nmoles carnitine 
ml blood 
I.S. = inverse slope, 
50 the appropriate factor to bring volume of carnitine 
up to 1 ml (20 µl x 50 = 1 ml), and 
CPM counts per minute. 
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For each sample, the Free, True ASAC, and AIAC fractions were added up 
to give the amount of total carnitine. The True ASAC was calculated as: 
ASAC - Free= True ASAC. This was done because when the ASAC fraction 
was hydrolyzed by KOH, both ASAC and Free carnitine were liberated. 
Thus, for total carnitine, the following equation was utilized: 
Free+ True ASAC + AIAC = Total Carnitine (TC) 
Statistical Methods 
The students'!_ test (30) was utilized in Experiment I to evaluate 
the effects of supplementary carnitine on weight and blood-ethanol 
levels between the control and the test group. Analysis of variance, 
and when significant, the Duncan's New Multiple Range Test (31) was used 
in Experiment II to evaluate the effects of carnitine on blood-ethanol 
and blood-carnitine levels as well as on weight comparisons between the 
individual supplemented groups. "Linear Regression" was used to 
determine the rates of ethanol disappearance from the blood in both 
experiments, while the Pearson's "r" was utilized to correlate all lines 
(30, 31) • For all data analyzed, the minimal level of statistical 
significant acceptance was .E. < 0.05. 
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CHAPTER IV 
RESULTS 
Experiment I 
The effects of 1% (w/w) carnitine on body weights are presented in 
Table 2. The weight gain for the cbntrol group (32 g) was 23% higher 
than that for the carnitine group (26 g) after 6 days of treatment and 
the weight gains were significantly different. Blood-ethanol concen-
trations on day 6 at 2, 5, and 8 hours after an acute dose of ethanol 
(Table 3) were higher in the carnitine supplemented animals than in the 
control animals at all time intervals. These differences were statis-
tically significant at all time intervals. The data shown in Table 3 
are illustrated in Figure 1. It can be seen that at all times tested, 
blood-carnitine levels were consistently higher in the carnitine 
supplemented animals than in the controls. An extrapolation of these 
lines to zero time indicated that the initial levels of blood ethanol in 
the carnitine-fed rats were significantly higher than in the control 
animals (161.5 vs. 109.5 mg/dl, respectively). 
Experiment II 
The effects of different levels (0, 0.25, 0.5, 0.75, and 1% w/w) of 
carnitine on body weights of animals are presented in Table 4. The 
changes in body weights over a 5 day period were not statistically 
different even though a small loss in body weight was observed in all 
groups. 
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Table 2 
Body Weights (g) of Rats Fed a Control Diet and of Those Supplemented 
with 1% D,L-Carnitinel 
Parameters Control Carnitine 
Initial body . h 2 we1g t 222.8 ± 6.33a 224.0 ± 10. 77a 
Final body weight 254.8 ± 5.25a 250.0 ± 11.47a 
Weight gain 32.0 ± 2.87a 26.0 ± 1. 75b 
1There were 4 rats in each group. All animals were fed Purina Rat 
Chow 115012 for 6 days. The carnitine group received 1% supplementary 
D,L-carnitine (W/W) mixed in their diet. 
2 The values are group means± SEM and those in a line bearing the 
same superscript letter are not statistically different (E.. > 0.05). 
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Table 3 
Blood-Ethanol Concentration (mg/dl) at 2, 5, and 8 Hours 
Postethanol Administration in Rats 1Fed 1% Supplementary D,L-Carnitine 
Hours Blood-Ethanol Levels 2 
Postethanol 
Administration Control Carnitine 
2 84.0 ± 4.5a 126.0 ± 0.5b 
5 38.5 ± 12.0a 92.5 ± 8.0b 
8 2.5 ± l.Oa 33.0 ± 8.5b 
1There were 4 rats in each group. All animals were fed Purina Rat 
Chow #5012 with 1% supplementary D,L-carnitine for 6 days before 
administration of ethanol. 
2 The values are group means± SEM and those in a line bearing the 
same superscript letter are not statistically different (.E_ > 0.05). 
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Figure 1. Time Dependent Changes in Blood-Ethanol Levels of Rats 
Fed a Diet Supplemented with (1%, W/W) and without D,L-Carnitine. (Each 
point represents the mean± SEM for 4 animals. Slopes were determined 
by "Linear Regression.") 
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Table 4 
Body Weights (g) of Rats on Varying 1Levels 
of Supplementary D,L-Carnitine 
Body Weight Body Weight 
at the Start after 5 Days 
221. 0 ± 2.32rl 219.9 ± 1.03a 
219.9 ± 2.02a 218.4 ± 1.68a 
221.5 ± 1.44a 220.5 ± 3 .18a 
222.8 ± 1. 25a 220.5 ± 2.83a 
222.1 ± 2.45a 218. 4 ± 3.40a 
Mean 
Weight 
Change 
-1.37 ± 2.75a 
-1. 50 ± 3.71a 
-0.90 ± 1. 74a 
-2.23 ± 2.68a 
-3.70 ± 5.02a 
1 The values are mean± SEM for 3 rats in each group and those in a 
column bearing the same superscript letter are not statistically 
different (E. > 0.05). 
2All animals were fed Purina Rat Chow #5012 with indicated levels 
of supplementary D,L-carnitine (W/W) mixed in their diets. 
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The effect of carnitine dose on blood-ethanol concentration is 
shown in Table 5. At all hours of monitoring, blood levels of ethanol 
were significantly higher in all supplemented groups than in the 
controls. Among the supplemented groups, the ethanol levels were dose 
related, however, the increases were significantly different for O. 7 5 
and 1% over 0.25 and 0.5% at 2 hours, and for 1% over 0.25, 0.5, and 
0.75% at 5 and 8 hours postethanol administration. Thus, the magnitude 
of increase in blood-ethanol concentration was significantly higher at 
0.75 and 1% than at 0.25 and 0.5% of dietary carnitine administration at 
2 hours postet~anol administration. At 5 and 8 hours such significance 
can be attached only to 1% carnitine supplementation. 
The data in Table 5 show that the concentration of blood-ethanol 
was significantly decreased with time at all levels of carnitine supple-
mentation as well as in the control group. These decreases in ethanol 
concentrations over an 8 hour period are illustrated in Figure 2. 
Although the rate of decrease in blood-ethanol concentration was greater 
for the carnitine supplemented group (14.5-20.3 mg/dl/hr) than for the 
control (11.6-13.6 mg/dl/hr) the overall concentration of ethanol 
remained higher in the former groups than in the later. Among the 
carnitine supplemented groups the blood ethanol levels corresponded with 
the dose of carnitine; i.e., the higher the level of carnitine in the 
diet, the higher the blood-ethanol concentration. Extrapolation of the 
lines to a theoretical zero time concentration confirmed the observa-
tions made in the earlier experiment (Table 3, Figure 1). It must be 
noted however that the magnitude of change in ethanol disappearance is 
almost superimposable for the dietary carnitine level 0.25 and 0.5%. 
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Table 5 
Blood-Ethanol Concentrations (mg/dl) at 2, 5, and 8 Hours 
Postethanol Administration in Rats Fed Varying Levels 
of Supplementary D,L-Carnitinel,2 
D,L-Carnitine Hours Postethanol Dosage 
Supplementation 
(%)3 2 5 8 
0(3) 4 77. 0 ± 11. oaf 46.5 ± 14.5af 7.5 ± 
0.25(3) 128.0 ± 5.0bf 103.0 ± 5.5bg 40.0 ± 
0. 50 (3) 137.5 ± 4.5bf 93.5 ± 4.5bg 50.5 ± 
0.75(3) 177. 0 ± 4.0cf 116. 0 ± 2.5bg 55.0 ± 
1.0(3) 213.5 ± 10.5cf 170.0 ± 20.0cg 118. 5 ± 
2.5ag 
6 _0abh 
5.5bh 
8.5bh 
24.0cg 
1 SEM and those in column bearing the Values are group means ± a 
same superscript letter (a-c) are not statistically different (.E_ > 
0.05). 
2 Values are group means± SEM and those in a line bearing the same 
superscript letter (f-h) are not statistically different (.E_ > 0.05). 
3All animals were fed Purina Rat Chow #5012 with indicated levels 
of supplementary D,L-carnitine for 5 days before testing. 
4Number of animals per group. 
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The effect of dietary carnitine supplementation on the concentra-
tion of blood-carnitine itself is shown in Table 6. The blood-carnitine 
levels rose both with increasing percentages of dietary carnitine as 
well as with the increasing number of days on the carnitine supplemented 
diets. The carnitine level in the blood of the control group stayed 
approximately the same during the 5 day period, however, in all the 
supplemented groups the concentration of blood-carnitine (nmoles/ml) was 
significantly e,levated during this period. Blood-carnitine levels in 
all supplemented groups are significantly higher than the control group 
on each day with a dramatic rise in the 1% group. 
The pattern of change in blood-carnitine levels at various levels 
of dietary carnitine supplementation is illustrated in Figure 3. The 
systemic levels of carnitine reached a saturating concentration at 3 
days of 1% supplementation and at about 5 days of 0.5 and 0.75% supple-
mentation. At O. 25% supplementation the relationship remained linear 
for up to 5 days. 
Finally, a correlation between the percent of supplementary 
carnitine fed to rats for 5 days and the blood-ethanol levels at 2, 5, 
and 8 hours postethanol administration on the fifth day of feeding is 
shown in Table 7 and Figure 4. It can be observed that there was a 
positive correlation between the levels of carnitine supplemented and 
blood-ethanol levels at all hours of testing(.£ 0.84-0.93). 
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Table 6 
Blood-Carnitine Concentrations (nmoles/ml) after 1, 3, and 5 Days 
of Feeding Varying Levels of Supplementary D,L-Carnitinel,2 
D,L-Carnitine Days on Supplementary Carnitine 
Supplementation 
(%)3 1 3 5 
0(3)4 27.53 ± 0.62af 27.39 ± 3.64af 28.44 ± 4.30af 
0.25(3) 41.81 ± 2.18bf 58.30 ± l.28bg 81.33 ± 6.98bh 
0.50(3) 51.46 ± 3.64bf 90.99 ± 8.24cg 125.24 ± 9.00ch 
o. 75(3) 63.59 ± 2.12cf 84.89 ± 12.04cf 130.24 ± 3.65cg 
1.0(3) 79.41 ± 6.44df 150.69 ± 7.35dg 160.49 ± 5.65dg 
1 Values are group means ± SEM and those in a column bearing the 
same superscript letter (a-d) are not statistically different (E.. > 
0.05). 
2
values are group means± SEM and those in a line bearing the same 
superscript letter (f-h) are not statistically different (.£. > 0.05). 
3All animals were fed Purina Rat Chow #5012 with indicated levels 
of supplementary D,L-carnitine. 
4 Number of animals per group. 
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Table 7 
Rela·tionship between Supplementary Carnitine Levels for 5 Days 
and Blood-Ethanol Concentrations in Rats on the 5th Day 
at 2, 5, and 8 Hours Postethanol Administrationl,2 
D,L-Carnitine 
Supplementation 
(%) (W/W)3 
Ethanol Concentration in Blood (mg/dl) 
0(3) 4 
0. 25 (3) 
0.50(3) 
0.75(3) 
1. 0(3) 
2 Hrs. 
77.0 ± 11.0af 
128.0 ± 5.0bf 
137.5 ± 4.Sbf 
177.0 ± 4.0cf 
213.5 ± 10.Scf 
5 Hrs. 
46.5 ± 14.Saf 
103.0 ± s.sbg 
93.5 ± 4.Sbg 
116.0 ± 2.Sbg 
170.0 ± 20.0bg 
8 Hrs. 
7.5 ± 2.Sag 
40.0 ± 6.0abh 
so.s ± s.sbh 
55.0 ± 8.Sbh 
118.5 ± 24.0cg 
1 Values are group means ± SEM and those in a column bearing the 
same superscript letter (a-c) are not statistically different (.e_ > 
0.05). 
2 Values are group means± SEM and those in a line bearing the same 
superscript letter (f-h) are not statistically different (.e_ > 0.05). 
3All animals were fed Purine Rat Chow #5012 with indicated levels 
of supplementary D,L-carnitine for 5 days before testing. 
4Number of animals per group. 
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CHAPTER V 
DISCUSSION 
The primary focus of this study was to examine the systemic levels 
of ethanol following an acute dose in rats fed a diet supplemented with 
crystalline D ,L-carnitine. This search was prompted by the· fact that 
Sachan et al. (7, 8) had found a significant reduction in ethanol-
induced hepatic steatosis in rats whose diet was supplemented with 
exogenous carnitine. They had suggested that carnitine may be bringing 
about the lipotropic effect by altering the rate of ethanol metabolism. 
The data shown in Tables 3 and 5 (pp. 23 and 28) clearly show 
higher concentrations of ethanol in the blood of rats given supplemen-
tary carnitine than those not provided with additional carnitine in 
their diet. Further, the effect of carnitine was evident at all the 
supplemented levels (0.25-1.0%, W/W). The higher blood-ethanol levels 
in the carnitine supplemented animals than in the controls was thought 
to be due to either a slow removal of ethanol from the systemic circula-
tion or due to a rapid entry of ethanol into the blood from the gastro-
intestinal tract (32). 
The rate of ethanol removal from the systemic circulation was 
evaluated by monitoring the changes in blood-ethanol concentrations at 
different time intervals following an acute dose of ethanol in the two 
groups of animals at a fixed level of supplemental carnitine (Table 3 
and Figure 1, pp. 24 and 25), and at variable supplemental levels of 
carnitine (Table 5 and Figure 2, pp. 28 and 29). The rates of ethanol 
r 
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disappearance, calculated from the slopes of the lines in Figures 1 and 
2, showed difference between carnitine supplemented groups and the con-
trols in both experiments. The rates for the controls were 13.6 mg/dl/ 
hr (Figure 1) and 11.6 mg/dl/hr (Figure 2) and those for the carnitine 
supplemented animals 15. 5 mg/ dl/hr (Figure 1) and 14. 5- 20. 3 mg/ dl/hr 
(Figure 2). Therefore, it is concluded that the higher levels of blood-
ethanol in the carnitine fed animals than that found in the control 
animals were not due to a slow rate of ethanol disappearance from their 
systemic circulation. Thus, the effect of carnitine on blood-ethanol 
concentration does not appear to be like that of chloral hydrate (17) or 
chlorpromazine (18) which act by inhibiting the ADH and prolonging the 
half-life of ethanol. Further, the effect of carnitine is also unlike 
that of various organic and inorganic nitrates which too inhibit ethanol 
clearance (20). 
Since the rate of ethanol removal in the carnitine supplemented 
animals was not slower than in the controls, an alternate explanation 
for the different blood-ethanol concentrations in the two groups of 
animals may lie in altered rates of ethanol absorption caused by 
carnitine. An estimation of blood-ethanol levels at or near zero time 
following ethanol administration can be made by extrapolating the lines 
used for calculating the disappearance rates of ethanol (Figures 1 and 
2). Such an approach showed that the ethanol concentration in the blood 
of carnitine treated animals was significantly higher, (161.5-246/5 
37 
mg/dl), than that present in the controls, (101. 5-109. 5 mg/ dl), at or 
near zero time following ethanol administration. These observations 
must be supported by further investigations in which ethanol appearance 
in blood must be followed with time immediately after ethanol adminis-
tration. 
In dealing with any alteration of ethanol absorption, the pharmaco-
kinetics which encompass its absorption must be considered because it 
involves the passage across the mucosal cellular membranes (32). In the 
intestinal epithelium there exists a single layer of cells that are 
going through ~onstant removal, (slough-off), repair, and regeneration, 
and any alteration of these processes could alter ethanol absorption due 
to its lipid solubility and rapid absorption by the gastric and intesti-
nal mucosa (3, 32). Pirola (15) found that drugs which promote gastric 
emptying, such as metoclopramide, a gastric antacid, may accelerate the 
rate of ethanol absorption because of their cholinergic activity. In 
studies done on humans with . diagnosed carnitine deficiencies (5, 33, 
34), it was observed that the administration of oral doses of L-carni-
tine caused diarrhea and gastrointestinal disturbance during the first 
stages of treatment, possibly due to an irritation of the intestinal 
mucosa. When the mucosal cells are regenerated, acylcarnitines may be 
incorporated into the cellular matrix in such a way as to alter the 
permeability of membranes. Hahn et al. (35) found that dietary carni-
tine enhanced the effect of norepinephrine in laboratory animals. 
Norepinephrine is known to cause relaxation and decreased motility of 
the small intestines, which may promote ethanol absorption. Carnitine 
modulated potentiation of norepinephrine effect may further facilitate 
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ethanol metabolism by accelerating other metabolic processes (5, 6, 36, 
37, 38). 
While the effects of supplemental carnitine on gain in body weights 
were not consistent between experiments (Tables 2 and 4, pp. 23 and 26), 
carnitine produced significant changes in the levels of blood-carnitine 
(Table 6, p. 31). The response to increasing levels of carnitine 
supplementation was progressive after 1, 3, and 5 days of carnitine 
feeding. Thus, the alterations in blood-carnitine levels were dose 
dependent. While a carnitine dose of 1% appeared to saturate the svstem 
in 3 days, a O. 25% dose remained linear for up to 5 days of feeding. 
The effects of 0.5 and 0.75% dose was intermediate, and saturated the 
system in about 5 days of feeding (Figure 3, p. 32). From these data it 
can be said that saturating levels of carni tine in the blood can be 
obtained by feeding 1% D,L-carnitine for 3 days and 0.5 and 0.75% 
D,L-carnitine for about 5 days. At the 0.25% level of supplementation, 
the time required for saturating the system may be more than 5 days. 
Increased levels of blood-ethanol in carnitine supplemented animals 
was caused by the levels of carnitine present in the diet. This is 
supported by the positive correlation (.£ = 0. 84-0. 93) between blood-
ethanol levels and the supplemental levels of carnitine (Table 7 and 
Figure 4, pp. 33 and 34). Whether parenteral administration of carni-
tine at these doses will cause similar changes in blood-ethanol deserves 
additional research. 
39 
CHAPTER VI 
SUMMARY 
This study was undertaken to examine possible alterations of 
ethanol metabolism in rats fed supplementary levels of crystalline 
D,L-carnitine. 
Male Sprague-Dawley rats of 200-250 g were assigned to ad libitum 
feeding of ground Purina Rat Chow as such or supplemented with O. 25, 
0.50, 0.75, and 1.0% (W/W) carnitine for 1-6 days. A dose of ethanol, 
(3 mg/kg body weight), was administered via a gastric gavage and blood-
ethanol as well as blood-carni tine levels were monitored in the tail 
blood at 2, 5, and 8 hours postethanol administration. 
The results show that the animals administered carnitine at all 
levels of supplementation had higher blood-ethanol concentrations than 
those not supplemented with carnitine. This response to carnitine sup-
plementation was dose dependent and blood-ethanol and carnitine doses 
were highly correlated, (!_ = 0. 84-0. 93), especially at 2 hours post-
ethanol administration (!_ = 0.93). Increases in blood-carnitine levels 
were also dose dependent and steady state levels were reached in 3 days 
at 1%, and at 5 days at 0.5 and 0. 75% carnitine supplementation. At 
0.25% supplementation, increases in blood-carnitine remained linear with 
time for up to 5 days. 
Thus, elevated blood-ethanol levels were caused by carnitine in the 
diet. However, the higher levels of blood-ethanol were not due to 
slower rates of ethanol disappearance from the blood in carnitine 
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supplemented rats versus those without supplementation. It is suggested 
that perhaps carnitine enhanced ethanol absorption from the GI tract 
since theoretical zero time blood-ethanol concentrations were signifi-
cantly higher in supplemented rats than in those not supplemented with 
carnitine. 
Thus carnitine supplementation increases blood-ethanol concentra-
tion following an oral dose which is not due to a decreased rate of 
ethanol clearance from the blood. The answer perhaps lies in different 
rates of ethanol absorption due to carnitine. 
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